Safety of SGLT2 inhibitors versus DPP-4 inhibitors in super-elderly…
SGLT2 inhibitors appear safer than alternative diabetes drugs for very elderly patients, with evidence suggesting lower mortality risk across multiple safety measures.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Real-World Associations of KidneyIntelX Risk Stratification With…
AI-guided kidney disease risk assessment helps doctors prescribe proven treatments more often, meaningfully improving outcomes for diabetic kidney disease patients.
Near-term implementable findingGLP-1 receptor agonists in pediatric obesity and diabetes
GLP-1 drugs show meaningful weight and blood sugar benefits in children with obesity and diabetes, offering options as childhood obesity rates climb.
Early cancer detection or preventionComputer-aided detection in surveillance colonoscopy
Computer-aided detection during colon cancer screening finds more dangerous polyps, strengthening cancer prevention in routine clinical practice.
Near-term implementable findingBreastfeeding and risk of maternal type 2 diabetes
Breastfeeding independently lowers mothers' long-term type 2 diabetes risk in a dose-dependent way, supporting this simple preventive strategy at population scale.